Jennison Associates
ALXN

Jennison Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-21,575
Closed -$3.3M 739
2021
Q1
$3.3M Hold
21,575
﹤0.01% 501
2020
Q4
$3.37M Buy
+21,575
New +$3.37M ﹤0.01% 470
2020
Q3
Sell
-33,182
Closed -$3.72M 707
2020
Q2
$3.72M Sell
33,182
-326,536
-91% -$36.6M ﹤0.01% 440
2020
Q1
$32.3M Sell
359,718
-1,503,312
-81% -$135M 0.04% 191
2019
Q4
$201M Sell
1,863,030
-181,059
-9% -$19.6M 0.2% 66
2019
Q3
$200M Sell
2,044,089
-6,969,813
-77% -$683M 0.21% 60
2019
Q2
$1.18B Sell
9,013,902
-1,227,555
-12% -$161M 1.17% 25
2019
Q1
$1.38B Buy
10,241,457
+1,512,545
+17% +$204M 1.37% 23
2018
Q4
$850M Buy
8,728,912
+101,376
+1% +$9.87M 0.95% 31
2018
Q3
$1.2B Buy
8,627,536
+2,599,414
+43% +$361M 1.1% 26
2018
Q2
$748M Sell
6,028,122
-1,459,471
-19% -$181M 0.73% 41
2018
Q1
$835M Buy
7,487,593
+2,466,428
+49% +$275M 0.83% 41
2017
Q4
$600M Sell
5,021,165
-311,471
-6% -$37.2M 0.59% 46
2017
Q3
$748M Buy
5,332,636
+4,682,336
+720% +$657M 0.77% 37
2017
Q2
$79.1M Sell
650,300
-8,976,179
-93% -$1.09B 0.08% 198
2017
Q1
$1.17B Buy
9,626,479
+1,350,652
+16% +$164M 1.25% 21
2016
Q4
$1.01B Buy
8,275,827
+1,138,592
+16% +$139M 1.13% 25
2016
Q3
$875M Buy
7,137,235
+43,840
+0.6% +$5.37M 0.94% 31
2016
Q2
$828M Sell
7,093,395
-216,732
-3% -$25.3M 0.91% 32
2016
Q1
$1.02B Sell
7,310,127
-35,897
-0.5% -$5M 1.07% 27
2015
Q4
$1.4B Buy
7,346,024
+481,031
+7% +$91.8M 1.38% 18
2015
Q3
$1.07B Buy
6,864,993
+913,030
+15% +$143M 1.1% 23
2015
Q2
$1.08B Buy
5,951,963
+711,725
+14% +$129M 0.99% 26
2015
Q1
$908M Sell
5,240,238
-553,113
-10% -$95.9M 0.83% 33
2014
Q4
$1.07B Sell
5,793,351
-2,589,663
-31% -$479M 1% 26
2014
Q3
$1.39B Buy
8,383,014
+234,768
+3% +$38.9M 1.29% 12
2014
Q2
$1.27B Sell
8,148,246
-232,924
-3% -$36.4M 1.17% 15
2014
Q1
$1.28B Sell
8,381,170
-16,719
-0.2% -$2.54M 1.22% 14
2013
Q4
$1.12B Sell
8,397,889
-237,117
-3% -$31.6M 1.1% 20
2013
Q3
$1B Sell
8,635,006
-1,023,542
-11% -$119M 1.05% 20
2013
Q2
$891M Buy
+9,658,548
New +$891M 1% 26